AMGEN Trademark

Trademark Overview

On Wednesday, August 7, 1996, a trademark application was filed for AMGEN with the United States Patent and Trademark Office. The USPTO has given the AMGEN trademark a serial number of 75146659. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, June 23, 2018. This trademark is owned by Amgen Inc.. The AMGEN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, erythropoietin for use in treating chronic anemia, granulocyte colony stimulating factor and granuloctye-macrophage colony stimulating factor for use in restoring the level of white blood cells, [ hepatitis B vaccine, ] interferon and interleukin 2 for use in anticancer and antiviral applications, epidermal growth factor and platelet derived growth * factor * for use in treating surgical or soft tissue damage; [ and pharmaceutical preparations for animal health care, namely, bovine somatotropin for use in increasing milk yield in dairy cattle and porcine somatotropin for use in reducing the fat content of pork ]
amgen

General Information

Serial Number75146659
Word MarkAMGEN
Filing DateWednesday, August 7, 1996
Status800 - REGISTERED AND RENEWED
Status DateSaturday, June 23, 2018
Registration Number2170735
Registration DateTuesday, July 7, 1998
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 14, 1998

Trademark Statements

Certificate of Correction for RegistrationIn the statement, Column 1, line 1 after growth, "factor" should be inserted.
Goods and Servicespharmaceutical preparations, namely, erythropoietin for use in treating chronic anemia, granulocyte colony stimulating factor and granuloctye-macrophage colony stimulating factor for use in restoring the level of white blood cells, [ hepatitis B vaccine, ] interferon and interleukin 2 for use in anticancer and antiviral applications, epidermal growth factor and platelet derived growth * factor * for use in treating surgical or soft tissue damage; [ and pharmaceutical preparations for animal health care, namely, bovine somatotropin for use in increasing milk yield in dairy cattle and porcine somatotropin for use in reducing the fat content of pork ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 11, 1996
Primary Code005
First Use Anywhere DateSunday, November 30, 1986
First Use In Commerce DateSunday, November 30, 1986

Trademark Owner History

Party NameAmgen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Friday, April 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 23, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, June 23, 2018REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Saturday, June 23, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, June 23, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 13, 2018TEAS SECTION 8 & 9 RECEIVED
Friday, July 7, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, July 5, 2008REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, July 5, 2008REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, July 1, 2008ASSIGNED TO PARALEGAL
Thursday, June 19, 2008TEAS SECTION 8 & 9 RECEIVED
Monday, August 13, 2007CASE FILE IN TICRS
Tuesday, July 20, 2004REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, June 11, 2004REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Friday, June 11, 2004TEAS SECTION 8 & 15 RECEIVED
Wednesday, April 14, 2004CORRECTION UNDER SECTION 7 ¿ PROCESSED
Saturday, January 24, 2004CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, October 6, 2003SEC 7 REQUEST FILED
Tuesday, July 7, 1998REGISTERED-PRINCIPAL REGISTER
Tuesday, April 14, 1998PUBLISHED FOR OPPOSITION
Friday, March 13, 1998NOTICE OF PUBLICATION
Saturday, February 7, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 3, 1998EXAMINER'S AMENDMENT MAILED
Monday, August 4, 1997FINAL REFUSAL MAILED
Wednesday, June 18, 1997CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 30, 1997NON-FINAL ACTION MAILED
Wednesday, January 22, 1997ASSIGNED TO EXAMINER

Related Keywords

amgen factor stimulating somatotropin pharmaceutical colony preparations growth namely treating health